TARPLIN, DOWNS & YOUNG, LLC

Lobbying for SAREPTA THERAPEUTICS · A biopharmaceutical company focused on innovative RNA-based therapeutics

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $90,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Budget/Appropriations

federal budget issues

Health Issues

Lobbying related to rare disease policy

Medicare/Medicaid

Lobbying related to rare disease policy and coverage

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.